Aditxt, Inc. Amortization of Debt Discount (Premium)
Aditxt, Inc. (ADTX) reported Amortization of Debt Discount (Premium) of $24.69 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-05-20
- Aditxt, Inc. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $24.69K, a 87.67% decline year-over-year.
- Aditxt, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $60.00K, a 78.02% decline year-over-year.
- Aditxt, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $234.17K, a 86.30% decline year-over-year.
- Aditxt, Inc. amortization of debt discount (premium) for the quarter ending 2025-06-30 was $1.21M, a 117.75% increase year-over-year.
- Aditxt, Inc. amortization of debt discount (premium) for fiscal 2025 was $1.71M, a 46.24% decline from fiscal 2024.
- Aditxt, Inc. amortization of debt discount (premium) for fiscal 2024 was $3.17M, a 44.66% increase from fiscal 2023.
- Aditxt, Inc. amortization of debt discount (premium) for fiscal 2023 was $2.19M, a 43.16% increase from fiscal 2022.
- Aditxt, Inc. amortization of debt discount (premium) for fiscal 2022 was $1.53M, a 16.92% decline from fiscal 2021.
| Period end | Amortization of Debt Discount (Premium) 0 month | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $24.69K 10-Q · filed 2026-05-20 | $84.69K derived: sum of 2 quarters · filed 2026-05-20 | $318.85K derived: sum of 3 quarters · filed 2026-05-20 | $1.53M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $294.17K derived: sum of 2 quarters · filed 2026-03-31 | $1.51M derived: sum of 3 quarters · filed 2026-03-31 | $1.71M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $234.17K 10-Q · filed 2025-11-18 | $1.45M derived: sum of 2 quarters · filed 2025-11-18 | $1.65M 10-Q · filed 2025-11-18 | $1.92M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-06-30 | $1.21M 10-Q · filed 2025-08-14 | $1.41M 10-Q · filed 2025-08-14 | $1.69M derived: sum of 3 quarters · filed 2026-05-20 | $3.40M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-03-31 | $200.28K 10-Q · filed 2026-05-20 | $473.25K derived: sum of 2 quarters · filed 2026-05-20 | $2.18M derived: sum of 3 quarters · filed 2026-05-20 | $2.74M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-12-31 | $272.96K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.98M derived: sum of 2 quarters · filed 2026-03-31 | $2.54M derived: sum of 3 quarters · filed 2026-03-31 | $3.17M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.71M 10-Q · filed 2025-11-18 | $2.27M derived: sum of 2 quarters · filed 2025-11-18 | $2.90M 10-Q · filed 2025-11-18 | $4.18M derived: sum of 4 quarters · filed 2025-11-18 | |
| 2024-06-30 | $556.71K 10-Q · filed 2025-08-14 | $1.19M 10-Q · filed 2025-08-14 | $2.47M derived: sum of 3 quarters · filed 2025-08-14 | $3.21M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $635.71K 10-Q · filed 2025-05-15 | $1.91M derived: sum of 2 quarters · filed 2025-05-15 | $2.65M derived: sum of 3 quarters · filed 2025-05-15 | $2.82M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.02M derived: sum of 2 quarters · filed 2025-03-31 | $2.18M derived: sum of 3 quarters · filed 2025-03-31 | $2.19M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $744.96K 10-Q · filed 2024-11-18 | $907.85K derived: sum of 2 quarters · filed 2024-11-18 | $921.24K 10-Q · filed 2024-11-18 | $921.24K derived: sum of 4 quarters · filed 2024-11-18 | |
| 2023-07-03 | $164.78K 10-K · filed 2024-04-16 | ||||
| 2023-06-30 | $162.89K 10-Q · filed 2024-08-19 | $176.29K 10-Q · filed 2024-08-19 | $176.29K derived: sum of 3 quarters · filed 2024-08-19 | $1.71M derived: sum of 4 quarters · filed 2024-08-19 | |
| 2023-03-31 | $13.39K 10-Q · filed 2024-05-20 | $13.39K derived: sum of 2 quarters · filed 2024-05-20 | $1.54M derived: sum of 3 quarters · filed 2024-05-20 | $1.55M derived: sum of 4 quarters · filed 2024-05-20 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.53M derived: sum of 2 quarters · filed 2024-04-16 | $1.53M derived: sum of 3 quarters · filed 2024-04-16 | $1.53M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $1.53M 10-Q · filed 2023-11-14 | $1.53M derived: sum of 2 quarters · filed 2023-11-14 | $1.53M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $2.95K 10-Q · filed 2023-08-14 | $2.95K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.19M derived: sum of 2 quarters · filed 2023-04-17 | $1.58M derived: sum of 3 quarters · filed 2023-04-17 | $1.85M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $1.19M 10-Q · filed 2022-11-14 | $1.58M derived: sum of 2 quarters · filed 2022-11-14 | $1.85M 10-Q · filed 2022-11-14 | $1.85M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $384.02K 10-Q · filed 2022-08-15 | $654.10K 10-Q · filed 2022-08-15 | $654.10K derived: sum of 3 quarters · filed 2022-08-15 | $654.10K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $270.08K 10-Q · filed 2022-05-16 | $270.08K derived: sum of 2 quarters · filed 2022-05-16 | $270.08K derived: sum of 3 quarters · filed 2022-05-16 | $405.47K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $135.39K derived: sum of 3 quarters · filed 2022-03-31 | $300.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $135.39K derived: sum of 2 quarters · filed 2021-11-15 | $300.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $135.39K 10-Q · filed 2021-08-12 | $300.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $164.61K 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |